IDENTITY

MATERIALITY andSUSTAINABILITY

BUSINESS andSTRATEGIESFINANCIAL INFORMATION /OTHERSGOVERNANCE

At a glance

The JT Group is a leading global tobacco company and our products are sold in over 130 markets. In addition to the tobacco business, we operate pharmaceutical and processed food businesses.
Revenue (2022)
Processed foodbusiness 5.9%

Others 0.1%

Number of employees (As of December 31, 2022)
Processed foodbusiness 8.2%

2,657.8

52,640Tobaccobusiness 91.0%

The Group’s tobacco business has the third largest sales
volume in the world* and includes 3 of the top 10 global
selling combustible brands in its product portfolio.

consumers’ trust. As of the end of 2022, the Group operates
5 factories in Japan (3 manufacturing tobacco and 2 tobacco-related factories), and 33 factories in 27 other countries(including tobacco-related factories).

The Group has a global manufacturing footprint and aims
to manufacture quality tobacco products that secure* Excluding China National Tobacco Corporation

Key market shares in tobacco business (As of December 31, 2022)

employees(JPY BN)

Pharmaceuticalbusiness 3.1%

Others 1.6%Global business foundation

Pharmaceuticalbusiness 2.5%

ROMANIA

27.4%

Tobaccobusiness 87.7%

29.5%
RUSSIA*

ITALY

36.6%

U.K.

Tobacco business

45.1%

The tobacco business, headquartered in Geneva, Switzerland since 2022, manufacturesand offers tobacco products all over the world.

JAPAN*SPAINTAIWAN

28.5%

Its key markets include Italy, Japan, Romania, Russia, Spain, Taiwan, the Philippines, theU.K, and Turkey, with leading brands in combustibles, such as Winston, Camel, MEVIUS
and LD, as well as in RRP (Reduced-Risk Products),* such as Ploom and Logic.

TURKEYTHE PHILIPPINES

27.8%

37.1%

42.4%

48.9%

* RRP (Reduced-Risk Products): Products with the potential to reduce the risks associated with smoking* Market size data for Japan and Russia reflects total tobacco figures of combustibles and RRP

Pharmaceutical business
The pharmaceutical business focuses on the R&D, manufacturing, and sale of prescription drugs, concentrating on three specific therapeutic areas: Cardiovascular, Renal andMetabolism (CVRM); immunology; and neuroscience.
Its products include CORECTIM® Ointment 0.25% and CORECTIM® Ointment 0.5%,
Riona® Tablets 250mg and ENAROY® Tablets 2 mg • 4 mg, among others.

Processed food business
The processed food business is present in the frozen and ambient food business, mainly
for frozen noodles, frozen okonomiyaki (Japanese savory pancakes), and packaged cooked
rice, and the seasonings business, focusing on seasonings including yeast extracts.
Major products include Reito-Sanuki-Udon (frozen noodles), Gottsu-umai okonomiyaki(Japanese savory pancakes), and HIMAX (yeast extract seasoning) in particular.

006

Japan Tobacco Inc. Integrated Report 2022Factories (As of December 31, 2022)

38

Tobacco businessfactories(Japan: 5, other countries: 33)

Processed food businessfactories(Japan: 15, other countries: 8)23

Note: There are no factories in the pharmaceutical businessTobacco factories
Europe: 11
Middle East/Africa: 8
Asia: 9North America: 1
Central and South America: 1n

Other tobacco-related factories
Europe: 2
Middle East/Africa: 2
Asia: 3
North America: 1n

Processed food factories
Asia: 22
North America: 1n

Japan Tobacco Inc. Integrated Report 2022007